A Resource for Healthcare and Social Services Professionals
Attend a free live training event! Browse trainings by topic, month, or event format (virtual or in-person), and then be sure to register online. Please note this list of upcoming trainings is updated regularly. If you do not see a specific training listed below, please check back or email us with any questions. If you want to be notified of newly booked trainings, subscribe to our mailing list.
DEA-eligible
Topic: Buprenorphine
This one-hour training prepares nurses and other medical professionals to use monthly injectable buprenorphine in addiction treatment.
 |
Friday, 2/28/2020 12:00 pm – 1:00 pm ET |
 |
In-person event |
 |
Intended AudienceAttendance is required for all OBAT nurses and MAs who work in a DPH/BSAS funded STATE OBOT program. All others working with patients on injectable buprenorphine are welcome and encouraged to attend. |
Topic: Buprenorphine
This event is intended to provide eight hours of required training for providers seeking their buprenorphine waivers
|
Wednesday, 3/4/2020 2:00 pm – 6:00 pm ET |
|
In-person event |
|
Intended AudiencePhysicians (MD, DO), Nurse Practitioners, and Physician Assistants |
Topic: Buprenorphine
This training will prepare prescribers to handle practical considerations when treating patients with opioid use disorders in office settings.
|
Monday, 3/9/2020 12:00 pm – 2:00 pm ET |
|
In-person event |
|
Intended AudienceStaff of the Community Clinic of Maui dba MÄlama I Ke Ola Health Center |
Topic: Buprenorphine
This training will prepare prescribers to handle practical considerations when treating patients with opioid use disorders in office settings.
|
Tuesday, 3/10/2020 12:00 pm – 2:00 pm ET |
|
In-person event |
|
Intended AudienceStaff of the Community Clinic of Maui dba MÄlama I Ke Ola Health Center |
Topic: Buprenorphine
This one-hour training prepares nurses and other medical professionals to use monthly injectable buprenorphine in addiction treatment.
|
Friday, 3/20/2020 12:00 pm – 1:00 pm ET |
|
In-person event |
|
Intended AudienceAttendance is required for all OBAT nurses and MAs who work in a DPH/BSAS funded STATE OBOT program. All others working with patients on injectable buprenorphine are welcome and encouraged to attend. |
Topic: Buprenorphine
This training will provide a brief overview of the history, legislation, pharmacodynamics, and pharmacokinetics of buprenorphine and naloxone.
|
Thursday, 4/2/2020 5:00 pm – 6:00 pm ET |
|
In-person event |
|
Intended AudienceNurses and other clinical staff providing treatment for substance use disorders in an office-based setting. |
Topic: Buprenorphine
This training will provide a brief overview of the history, legislation, pharmacodynamics, and pharmacokinetics of buprenorphine and naloxone.
|
Friday, 4/3/2020 9:00 am – 10:00 am ET |
|
In-person event |
|
Intended AudienceNurses and other clinical staff providing treatment for substance use disorders in an office-based setting. |
Topic: Buprenorphine
This training, part three in a four-part series, will provide an overview of the logistics concerning the use of buprenorphine to treat opioid use disorder.
|
Thursday, 4/9/2020 7:00 pm – 8:00 pm ET |
|
In-person event |
|
Intended AudienceNurses and other medical staff providing treatment for substance use disorders in an office-based setting. |
Topic: Buprenorphine
This training, part three in a four-part series, will provide an overview of the logistics concerning the use of buprenorphine to treat opioid use disorder.
|
Friday, 4/10/2020 9:00 am – 10:00 am ET |
|
In-person event |
|
Intended AudienceNurses and other medical staff providing treatment for substance use disorders in an office-based setting. |
Topic: Buprenorphine
This one-hour training prepares nurses and other medical professionals to use monthly injectable buprenorphine (Sublocade) in addiction treatment.
|
Wednesday, 4/15/2020 12:00 pm – 1:00 pm ET |
|
In-person event |
|
Intended AudienceAttendance is required for all OBAT nurses and MAs who work in a DPH/BSAS funded STATE OBOT program. All others working with patients on injectable buprenorphine are welcome and encouraged to attend. |
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.